Ultrasound Beams as an Adjunct to Reperfusion Therapy in STEMI
- Conditions
- Myocardial InfarctionST Elevation Myocardial Infarction
- Registration Number
- NCT02299609
- Lead Sponsor
- Sakarya University
- Brief Summary
Successfully perfused STEMI patients will receive routine transthoracic echocardiography qid for 4 days or placebo. Myocardial function and infarct size will be evaluated at 3 and 6 months.
- Detailed Description
Patients who had acute STEMI and successfully reperfused by either thrombolytic therapy or primary angioplasty and stenting will be included this study.
A basal routine echocardiography will be obtained in all patients after reperfusion therapy. Thereafter, patients will be divided into two groups: 1.Treatment group will receive transthoracic echocardiography using Philips HD11 XE ® for 30 minutes qid for 4 days. 2. Placebo group will have the same Philips HD11 XE ® echo transducer applied for the same time and duration on their chest but with the ultrasound turned-off. Detailed left and right ventricle function as well as performance index and stress-strain imaging will be obtained and analyzed at 3 and 6 months.
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 100
Not provided
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Increase in left ventricular function At 3 and 6 months Ultrasound beams during echocardiography application expected to ameliorate the left ventricle function
- Secondary Outcome Measures
Name Time Method Decrease in infarct size At 3 and 6 months Ultrasound beams during echocardiography application expected to decrease infarct size
Trial Locations
- Locations (1)
Sakarya University, Faculty of Medicine
🇹🇷Sakarya, Turkey
Sakarya University, Faculty of Medicine🇹🇷Sakarya, TurkeyRamazan Akdemir, MDContact00905336020700rakdemir@yahoo.com